News

Nationwide Gummies Recall Update as FDA Issues Highest Risk Warning
Vita Warehouse Corp. recalled more than 40,000 bottles of Vitamin B12 supplements for possible undeclared presence of peanut.
STAT14m
Inside the staff exodus and tanking morale that threaten Makary’s FDA
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
Agence France-Presse16m
CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology
EU chief, Trump had 'good exchange' by phone Sunday CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S.
Is Your Meat Real or Lab-Grown? The USDA’s New Labeling Rules Aim to Make That Clear
This summer, the U.S. Department of Agriculture (USDA) is finalizing new national rules for labeling and marketing lab-grown ...
Hims & Hers’ ugly split with Wegovy maker weighs on the firm’s future
Hims & Hers, the high-flying online health company that rapidly grew from a buzzy startup selling Viagra to a multibillion-dollar business, had a hard month.
Mustang Bio stock soars after FDA grants orphan drug designation
Investing.com -- Mustang Bio Inc (NASDAQ: MBIO) stock surged over 78% after the U.S. Food and Drug Administration granted orphan drug designation to its MB-101 treatment for recurrent diffuse and ...
Lexeo Therapeutics stock rises after FDA breakthrough designation
Investing.com -- Lexeo Therapeutics Inc (NASDAQ: LXEO) stock rose 2.3% after the company announced that the U.S. Food and Drug Administration granted breakthrough therapy designation for its ...
Eli Lilly's 3-step strategy to dominate the $95 billion obesity market
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
US FDA approves KalVista Pharma's swelling disorder drug, shares rise
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral ...
ALS News Today1h
FDA grants orphan drug status to ALS gene therapy SNUG01
The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...
Lexeo Therapeutics Receives Breakthrough Therapy Designation for Rare Disease Treatment
Lexeo Therapeutics received a breakthrough therapy designation from the Food and Drug Administration for its treatment for Friedreich's ataxia. Ataxia is a rare, inherited disease that damages the ...